BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7679152)

  • 1. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs.
    Billman GE; Avendano CE; Halliwill JR; Burroughs JM
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):197-204. PubMed ID: 7679152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
    Billman GE; Englert HC; Schölkens BA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of K+ATP channels in coronary vasodilation during exercise.
    Duncker DJ; Van Zon NS; Altman JD; Pavek TJ; Bache RJ
    Circulation; 1993 Sep; 88(3):1245-53. PubMed ID: 8353886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels.
    Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.
    Ishibashi Y; Duncker DJ; Zhang J; Bache RJ
    Circ Res; 1998 Feb; 82(3):346-59. PubMed ID: 9486663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
    Billman GE
    Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calcium channel antagonist, flunarizine, protects against ventricular fibrillation.
    Billman GE
    Eur J Pharmacol; 1992 Mar; 212(2-3):231-5. PubMed ID: 1601065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in rats.
    Lu H; Remeysen P; De Clerck F
    Coron Artery Dis; 1993 Jul; 4(7):649-57. PubMed ID: 8281370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
    Billman GE; Houle MS; Englert HC; Gögelein H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):182-92. PubMed ID: 14722326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel.
    Chi L; Black SC; Kuo PI; Fagbemi SO; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):179-90. PubMed ID: 7679150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation in preconditioned pig hearts: role of K+ATP channels.
    Rioufol G; Ovize M; Loufoua J; Pop C; André-Fouät X; Minaire Y
    Am J Physiol; 1997 Dec; 273(6):H2804-10. PubMed ID: 9435617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels.
    Elliott GT; Mei DA; Gross GJ
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
    Yamamoto M; Egashira K; Arimura K; Tada H; Shimokawa H; Takeshita A
    Jpn Circ J; 2000 Sep; 64(9):701-7. PubMed ID: 10981856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs.
    Toller WG; Kersten JR; Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1999 Nov; 91(5):1437-46. PubMed ID: 10551596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow.
    Duncker DJ; van Zon NS; Ishibashi Y; Bache RJ
    J Clin Invest; 1996 Feb; 97(4):996-1009. PubMed ID: 8613554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
    Warltier DC; Auchampach JA; Gross GJ
    J Card Surg; 1993 Mar; 8(2 Suppl):279-83. PubMed ID: 8461517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of K(+)(ATP) channels and adenosine in regulation of coronary blood flow in the hypertrophied left ventricle.
    Melchert PJ; Duncker DJ; Traverse JH; Bache RJ
    Am J Physiol; 1999 Aug; 277(2 Pt 2):H617-25. PubMed ID: 10444487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
    Farouque HM; Worthley SG; Meredith IT
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):905-10. PubMed ID: 15016638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.